Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders

Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders

Dopamine metabolism, alpha-synuclein pathology, and iron homeostasis have all been implicated as potential contributors to the unique vulnerability of substantia nigra dopaminergic neurons which preferentially decline in Parkinson's disease and some rare neurodegenerative disorders with shared...

Full description

Bibliographic Details
Main Authors:	Rachel M. Wise, Annika Wagener, Urban M. Fietzek, Thomas Klopstock, Eugene V. Mosharov, Fabio A. Zucca, David Sulzer, Luigi Zecca, Lena F. Burbulla
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Series:	Neurobiology of Disease
Subjects:	Parkinson's disease Neurodegeneration with Brain Iron Accumulation Dopamine Alpha-synuclein Iron Neurodegeneration
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996122003126

Similar Items

Neurodegeneration with Brain Iron Accumulation Disorders: Valuable Models Aimed at Understanding the Pathogenesis of Iron Deposition
by: Sonia Levi, et al.
Published: (2019-02-01)

Editorial: Iron and neurodegeneration, volume II
by: Isabella Zanella, et al.
Published: (2022-12-01)

The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease
by: Georgia Minakaki, et al.
Published: (2020-12-01)

Editorial: Iron and Neurodegeneration
by: Giorgio Biasiotto, et al.
Published: (2019-12-01)

Emerging Disease-Modifying Therapies in Neurodegeneration With Brain Iron Accumulation (NBIA) Disorders
by: Vassilena Iankova, et al.
Published: (2021-04-01)

On the Role of Iron in Idiopathic Parkinson’s Disease
by: Sandro Huenchuguala, et al.
Published: (2023-11-01)

Interaction and Redox Chemistry between Iron, Dopamine, and Alpha-Synuclein C-Terminal Peptides
by: Fabio Schifano, et al.
Published: (2023-03-01)

Modelling α-Synuclein Aggregation and Neurodegeneration with Fibril Seeds in Primary Cultures of Mouse Dopaminergic Neurons
by: Aurore Tourville, et al.
Published: (2022-05-01)

An international registry for neurodegeneration with brain iron accumulation
by: Kalman Bernadette, et al.
Published: (2012-09-01)

Cerebral Iron Deposition in Neurodegeneration
by: Petr Dusek, et al.
Published: (2022-05-01)

Harmful Iron-Calcium Relationship in Pantothenate kinase Associated Neurodegeneration
by: Paolo Santambrogio, et al.
Published: (2020-05-01)

Vicious cycle of lipid peroxidation and iron accumulation in neurodegeneration
by: Irene Villalón-García, et al.
Published: (2023-01-01)

Neurodegeneration with inflammation is accompanied by accumulation of iron and ferritin in microglia and neurons
by: Maj Schneider Thomsen, et al.
Published: (2015-09-01)

Brain MRI Pattern Recognition in Neurodegeneration With Brain Iron Accumulation
by: Jae-Hyeok Lee, et al.
Published: (2020-09-01)

A Patient with Beta-Propeller Protein-Associated Neurodegeneration: Treatment with Iron Chelation Therapy
by: Shen-Yang Lim, et al.
Published: (2018-05-01)

Copper, Iron, and Manganese Toxicity in Neuropsychiatric Conditions
by: Beata Tarnacka, et al.
Published: (2021-07-01)

Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms.
by: Sonia eLevi, et al.
Published: (2014-05-01)

Post translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson’s disease
by: James A. Duce, et al.
Published: (2017-06-01)

Botulinum Toxin-A Injection in the Treatment of Spasticity in a Infantile-Onset Neurodegeneration With Brain Iron Accumulation: A Case Report
by: Hwan Kwon Do, et al.
Published: (2018-04-01)

Iron Homeostasis in the CNS: An Overview of the Pathological Consequences of Iron Metabolism Disruption
by: Christina A. Porras, et al.
Published: (2022-04-01)

High Iron and Iron Household Protein Contents in Perineuronal Net-Ensheathed Neurons Ensure Energy Metabolism with Safe Iron Handling
by: Anja Reinert, et al.
Published: (2022-01-01)

Iron in Neurodegeneration – Cause or Consequence?
by: Alain Ndayisaba, et al.
Published: (2019-03-01)

Iron Deposition in Brain: Does Aging Matter?
by: Eleonora Ficiarà, et al.
Published: (2022-09-01)

Temporal Evolution of Inflammation and Neurodegeneration With Alpha-Synuclein Propagation in Parkinson's Disease Mouse Model
by: Thuy Thi Lai, et al.
Published: (2021-10-01)

Pantothenate kinase-associated neurodegeneration: Clinical aspects, diagnosis and treatments
by: Saeed Razmeh, et al.
Published: (2018-04-01)

Neurodegeneration with brain iron accumulation: a differential diagnosis of cerebral palsy
by: Alana Ferreira de Andrade, et al.
Published: (2023-03-01)

Attenuation of Dopaminergic Neurodegeneration in a <i>C. elegans</i> Parkinson’s Model through Regulation of Xanthine Dehydrogenase (XDH-1) Expression by the RNA Editase, ADR-2
by: Lindsey A. Starr, et al.
Published: (2023-05-01)

Iron misregulation and neurodegenerative disease in mouse models that lack iron regulatory proteins
by: Manik C. Ghosh, et al.
Published: (2015-09-01)

A pilot trial of deferiprone in pantothenate kinase-associated neurodegeneration patients
by: Mohammad Rohani, et al.
Published: (2018-02-01)

Found in Translation: The Utility of <i>C. elegans</i> Alpha-Synuclein Models of Parkinson’s Disease
by: Anthony L. Gaeta, et al.
Published: (2019-03-01)

Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by α-synuclein
by: Chris McKinnon, et al.
Published: (2020-02-01)

α-Synuclein and Polyunsaturated Fatty Acids: Molecular Basis of the Interaction and Implication in Neurodegeneration
by: Chiara Fecchio, et al.
Published: (2018-06-01)

Neurodegeneration with Brain Iron Accumulation: Diagnosis and Management
by: Penelope Hogarth
Published: (2015-01-01)

α-Synuclein arginylation in the human brain
by: Jun Zhao, et al.
Published: (2022-04-01)

The Contribution of Iron to Protein Aggregation Disorders in the Central Nervous System
by: Karina Joppe, et al.
Published: (2019-01-01)

Neurodegeneration with brain iron accumulation
by: G. E. Rudenskaya, et al.
Published: (2017-02-01)

Long-Term Neuroradiological and Clinical Evaluation of NBIA Patients Treated with a Deferiprone Based Iron-Chelation Therapy
by: Nicola Romano, et al.
Published: (2022-08-01)

New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases
by: Marco T. Nuñez, et al.
Published: (2018-10-01)

Links Between Iron and Lipids: Implications in Some Major Human Diseases
by: Stephanie Rockfield, et al.
Published: (2018-10-01)

Developing Iron Nanochelating Agents: Preliminary Investigation of Effectiveness and Safety for Central Nervous System Applications
by: Eleonora Ficiarà, et al.
Published: (2024-01-01)